It is correct that they can receive income from the sale of the product and the data can be used as part of the trial. Once they get a CE mark which they say is not far off.
They then can commence sales in the EU
The device can be used to treat other solid tumours.
Once they get approval a doctor could use it off the shelf to treat specific tumours without further trials done
It is correct that they can receive income from the sale of the...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.79M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $15.59K | 1.950M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 33714048 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 53583 | 3 |
View Market Depth
| Last trade - 12.18pm 13/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |